Assessment of PENG Block as a Part of Multimodal Analgesia Following Hip Surgeries.

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 27, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Anesthesia
Interventions
DRUG

Pericapsular nerve group (PENG) block

"As a part of multimodal analgesia patients will receive 20 ml of 0.25% bupivcacaine according to the technique described by Giron-Arango.~All patients will receive the same analgesic protocol, which included IV paracetamol 1000 mg BID and NSAIDs if no contra-indication; PO celecoxib 100 mg BID. Also if needed nalbuphine 5 mg IV will be given as bolus demand dose and when the NRS pain score was equal to or greater than 4 points."

OTHER

Patients will receive only other multimodal analgesics including LCFN block via 10 ml of 0.25% bupivacaine.

Patients will receive only other multimodal analgesics including LCFN block via 10 ml of 0.25% bupivacaine.

Trial Locations (1)

11517

Faculty of medicine, Ain Shams University, Abbasia

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06916000 - Assessment of PENG Block as a Part of Multimodal Analgesia Following Hip Surgeries. | Biotech Hunter | Biotech Hunter